Portage Biotech Inc reports results for the quarter ended in December - Earnings Summary

Alpha Compute

01/03/2023 14:03

* Portage Biotech Inc  PRTG.OQ  reported a quarterly
adjusted loss
of 44 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 23 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Portage Biotech Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Portage Biotech Inc shares had fallen by 27.8% this
quarter.
    * The company reported a quarterly loss of $7.49 million.
    * Wall Street's median 12-month price target for Portage
Biotech
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 02:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.23          -0.44          Missed
 Sep. 30 2022      -0.29          -0.06          Beat
 Jun. 30 2022      -0.30          -0.13          Beat
 Mar. 31 2022      -0.28          -0.56          Missed